Source: Eur Respir J 2011; 37: 1439-1446
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Guertler C., Wirz B., Christ-Crain M., Zimmerli W., Mueller B., Schuetz P.. Inflammatory responses predict long-term mortality risk in community-acquired pneumonia. Eur Respir J 2011; 37: 1439-1446

Member's Comments

No comment yet.

Related content which might interest you: Management-based risk prediction in community-acquired pneumonia by scores and biomarkers Source: Eur Respir J 2013; 41: 974-984 Year: 2013 Prediction of in-hospital death from community-acquired pneumonia by varying CRB-age groups Source: Eur Respir J 2013; 41: 917-922 Year: 2013 Impact of immunosuppression on incidence, aetiology and outcome of ventilator-associated lower respiratory tract infections Source: Eur Respir J, 51 (3) 1701656; 10.1183/13993003.01656-2017 Year: 2018 3-day mortality in hospitalised community-acquired pneumonia: frequency and risk factors Source: Eur Respir J 2016; 47:1572-1574 Year: 2016 Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia Source: Eur Respir J 2007; 30: 517-524 Year: 2007 Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia Source: Eur Respir J 2009; 33: 153-159 Year: 2009 Prediction of complications development and lethal outcome in patients with community-acquired pneumonia Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura Year: 2011 Respiratory infections in the immunocompetent host: from asthma exacerbations to hospital-acquired pneumonia Source: Annual Congress 2007 - Infections year in review Year: 2007 COPD is associated with increased mortality in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: 346-351 Year: 2006 Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009 Community-acquired pneumonia in the elderly Source: Eur Respir Mon; 2009: 43: 111–132 Year: 2009 Initial management of pneumonia and sepsis: factors associated with improved outcome Source: Eur Respir J 2011; 39: 156-162 Year: 2012 Initial management of pneumonia and sepsis: factors associated with improved outcome Source: Eur Respir J 2012; 39: 156-162 Year: 2012 The impact of comorbidities on the in-hospital mortality in patients with community-acquired pneumonia Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015 Factors affecting short and long-term mortality after community-acquired pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 In-hospital mortality risk assessment in patients with community acquired pneumonia Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 Lower respiratory tract infections: when are antibiotics mandatory? Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=146 Year: 2004 Predictive factors of in-hospital mortality of patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 352s Year: 2006 Macrolide therapy is associated with lower 30-day mortality in patients with non-pneumonia and pneumonia severe sepsis Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011 Comparison of inflammatory response biomarkers to predict complications in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011